A cost-utility analysis of interferon beta for multiple sclerosis

MeSH terms

• Adjuvants, Immunologic / economics*
• Adjuvants, Immunologic / therapeutic use
• Adult
• Aged
• Cost-Benefit Analysis
• Decision Support Techniques
• Drug Costs*
• Female
• Health Status
• Humans
• Interferon-beta / economics*
• Interferon-beta / therapeutic use
• Male
• Medical Records
• Middle Aged
• Models, Econometric
• Multiple Sclerosis / drug therapy*
• Outcome Assessment, Health Care
• Quality-Adjusted Life Years
• United Kingdom